Induction of hyperacute rejection of skin allografts by CD8+ lymphocytes

Transplantation

Volumn 69, Issue 7, 2000, Pages 1452-1457

  Yoshimura, Rikio ^a,b   Chargui, Jamel ^a   Aitouche, Abdel ^a   Veyron, Paule ^a   Touraine, Jean Louis ^a,c  

^a UNIVERSITÉ LYON 1   (France)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC ANTIBODY;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; CONTROLLED STUDY; GRAFT REJECTION; GRAFT SURVIVAL; HUMORAL IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN ALLOGRAFT; T LYMPHOCYTE;

EID: 0034655388     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-200004150-00041     Document Type: Article

References (54)

1. Mason DW, Dallman MJ, Arthur RP, Morris PJ. Mechanisms of allograft rejection: the roles of cytotoxic T-cells and delayed-type hypersensitivity. Immunol Rev 1984; 77: 167.
2. Bradley JA, Sarawar SR, Porteus C, et al. Allogenic rejection in CD4+ T cell-reconstituted athymic nude rats: the nonessential role of host-derived CD8+ cells. Transplantation 1992; 53: 477.
3. Jefferson KP, Tyerman KS, McLeish M, Collier DS, Thiru S. Donor pretreatment prolongs survival of discordant xenografts. Transplant Proc 1991; 23: 2280.
4. Kitagawa S, Iwata H, Sato S, Shimizu J, Hamaoka T, Fujiwara H. Heterogenous graft rejection pathways in class I major histocompatibility-disparate combinations and their differential susceptibility to immunomodulation induced by intravenous presensitization with relevant alloantigens. J Exp Med 1991; 174: 571.
5. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
6. Mitchinson NA. Studies on the immunological response to foreign tumor transplantation in the mouse. The role of lymphnode cells in conferring immunity by adoptive transfer. J Exp Med 1955; 102: 157.
7. Billingham RE, Brent L, Medawar PB. Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of activity and adoptively acquired immunity. Proc R Soc Lond (Biol) 1954; 143: 58.
8. Miller FJA. Effect of neonatal thymectomy on the immunological responsiveness. Proc R Soc Lond (Biol) 1962; 156: 415.
9. + cells are essential for allorejection. J Exp Med 1996; 184: 2013.
10. Iwaki Y, Iguro T, Terasaki PI. Effect of sensitization on kidney allografts. In : Terasaki PI, ed. Clinical kidney transplants 1985, Los Angeles: UCLA Tissue Typing Laboratory, 1985; 139.
11. Alexandre GPJ, Squifflet JP, Bruyere M, et al. Present experiences in a series of 26 ABO-incompatible living donor renal allografts. Transplant Proc 1987; 19: 4538.
12. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O. Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells. Lancet 1966; 2: 662.
13. Cairns BA, deSerres S, Matsui M, Frelinger JA, Meyer AA. Cultured mouse keratinocyte allografts prime for accelerated second set rejection and enhanced cytotoxic lymphocyte response. Transplantation 1994; 58: 67.
14. Auchincloss H Jr, Ghobrial RRM, Russell PS, Winn HJ. Prevention of alloantibody formation after skin grafting without prolongation of graft survival by anti-L3T4 in vivo. Transplantation 1988; 45: 1118.
15. Hancock WW, Sayegh MH, Zhang ZJ, Kwok CA, Weiner AL, Carpenter CB. Oral immunization with allogeneic splenocytes inhibits development of accelerated but not acute rejection of cardiac grafts: analysis of intragraft effector mechanisms. Transplant Proc 1992; 24: 250.
16. Toyama N, Kobayasi E, Yamada S, Enosawa S, Miyata M. Fulminant second-set allograft rejection and endoscopic findings following small bowel transplantation in the rat. J Gastroenterol 1995; 30: 465.
17. Fryer JP, Leventhal JR, Dalmasso AP, et al. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets. Transplantation 1995; 59: 171.
18. Davenport C, Kumar V, Bennett M. Rapid rejection of H2 k and b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice. J Immunol 1995; 155: 3742.
19. Aitouche A, Touraine JL. Accelerated rejection of H-2-incompatible skin allografts in the absence of specific cytotoxic antibodies. Transplantation 1993; 56: 503.
20. Mombaerts P, Iacomini J, Johnson RS, Herrup K, Tonegawa S, Papaioannou VE. RAG-1-deficient mice have no mature B and T lymphocytes. Cell 1992; 68: 869.
21. Lowenberg B. Fatal liver transplantation. Rijswijk, The Netherlands: Radiological Institute of the Organization for Health Research TNO, 1975.
22. Billingham RE, Medawar PB. A technique for skin grafting in mammals. J Exp Biol 1951; 28: 385.
23. Gorer PA, O'Gorman P. The cytotoxic activity of isoantibodies in mice. Transplant Bull 1956; 3: 142.
24. Steinmuller D. Which T cells mediate allograft rejection? Transplantation 1985; 40: 229.
25. Loveland BE, McKenzie IFC. Which T cells cause graft rejection? Transplantation 1982; 33: 217.
26. Cerottini JC, Brunner KT. Cell mediated cytotoxicity, allograft rejection, and tumor immunity. Adv Immunol 1974; 18: 67.
27. Canty TG, Wunderlich JP. Quantitative assessment of cellular and humoral responses to skin and tumor allografts. Translantation 1971; 11: 111.
28. Ascher NL, Ferguson RM, Hoffman R, Simmons RL. Partial characterization of cytotoxic cells infiltrating sponge matrix allografts. Transplantation 1979; 27: 254.
29. Rouse BT, Wagner H. The in vivo activity of in vitro immunized mouse thymocytes. II. Rejection of skin allografts and graft-vs-host activity. J Immunol 1972; 109: 1282.
30. Loveland BE, Hogarth PM, Ceredig RL, McKenzie IFC. Cells mediating skin graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med 1981; 153: 1044.
31. Mizuochi T, Golding H, Rosenberg AS, Glimeher LH, Malek TR, Singer A. Both L3T4 and Lyt 2 helper T cells initiate cytotoxic T lymphocyte responses against allogenic major histocompatibility antigens but not against trinitrophenyl-modified self. J Exp Med 1985; 162: 427.
32. Singer A, Munitz TI, Golding H, Rosenberg AS, Mizuochi T. Recognition requirements for the activation, differentiation and function of T-helper cells specific for class I MHC alloantigens. Immunol Rev 1987; 98: 143.
33. Cantor H, Boyse EA. Functional subclasses of T lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T cell subclasses in a differentiative process independent of antigen. J Exp Med 1975; 141: 1376.
34. Cobbold S, Waldmann H. Skin allograft rejection by L3/T4+ and Lyt-2+ T cell subsets. Transplantation 1986; 41: 634.
35. Yamamoto N, Einaga-Naito K, Kuriyama M, Kawada Y, Yoshida R. Cellular basis of skin allograft rejection in mice : specific lysis of allogeneic skin components by non-T cells. Transplantation 1998; 65: 818.
36. Royo C, Touraine JL, Veyron P, Aitouche A. Survey of experimental data on fetal liver transplantation. Thymus 1987; 10: 5.
37. Sanhadji K, Touraine JL, Aitouche A. Vicari A, Chargui J, Goillot E. Fetal liver cell transplantation in various murine models. Bone Marrow Transplant 1992; 9 (Suppl 1): 77.
38. Touraine JL, Raudrant D, Vullo C et al. New developments in stem cell transplantation with special reference to the first in utero transplants in humans. Bone Marrow Transplant 1991; 7 (Suppl 3): 92.
39. Slavin S, Morecki S, Weigensberg M, Bar S, Weiss L. Functional clonal deletion versus suppressor cell-induced transplantation tolerance in chimeras prepared with a short course of total lymphoid irradiation. Transplantation 1986; 41: 680.
40. Wu GD, Cramer DV, Chapman FA, Oriol R, Makowka L. Genetic control of the humoral immune response to xenografts. I. Functional characterization of rat monoclonal antibodies to hamster heart xenografts. Transplantation 1995; 60: 1497.
41. Borie DC, Cramer DV, Shirwan H, et al. Genetic control of the humoral immune response to xenografts. II. Monoclonal antibodies that cause rejection of heart xenografts are encoded by germline immunoglobulin genes. Transplantation 1995; 60: 1504.
42. Magee JC, Collins BH, Harland RC, et al. Immunoglobulin prevents complement-mediated hyperacute rejection in swine-to-primate xenotransplantation. J Clin Invest 1995; 96: 2404.
43. Rice HE, Flake AW, Hedrick MH, Zanjani ED, Harrison MR. Effect of xenogeneic chimerism in a human/sheep model on natural antibody. J Surg Res 1993; 54: 355.
44. Calmus Y, Ayani E, Cardoso J, et al. Target antigens of hyperacute xenogeneic rejection in the rat to guinea pig to rat discordant combinations. Transplantation 1993; 56: 778.
45. Zehr KJ, Herskowitz A, Lee PC, Poston RS, Gillinov AM, Baumgartner WA. Neutrophil adhesion inhibition prolongs survival of cardiac allografts with hyperacute rejection. J Heart Lung Transplant 1993; 12: 837.
46. Zambello R, Trentin L, Cassatella MA, et al. IL-12 is involved in the activation of CD3+ granular lymphocytes in patients with lymphoproliferative disease of granular lymphocytes. Br J Haematol1996; 92: 308.
47. Astarcioglu I, Gugenheim J, Crafa F, Saint-Paul MC, Reynes M. Hyperacute rejection of liver allograft in sensitized rats: role of nonparenchymal liver cells. J Surg Res 1995; 58: 182.
48. Kaplon RJ, Platt JL, Kwiatkowski PA, et al. Absence of hyperacute rejection in pig-to-primate orthotopic pulmonary xenografts. Transplantation 1995; 59: 410.
49. Kaplon RJ, Michler RE, Xu H, Kwiatkowski PA, Edwards NM, Platt JL. Absence of hyperacute rejection in newborn pig-to-baboon cardiac xenografts. Transplantation 1995; 59: 1.
50. Braun WE. The immunobiology of different types of renal allograft rejection. In: Milford EL, Brenner BM, Stein JH, eds. Renal transplantation. New York: Churchill Livingstone,1989; 45.
51. Leventhal JR, John R, Fryer JP, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Results of in vitro and in vivo studies. Transplantation 1995; 59: 294.
52. Takahashi K, Tanabe K, Ooba S, et al. Prophylatic use of a new immunosuppressive agent, Deoxyspergualine, in patients with kidney transplantation from ABO-incompatible or preformed antibody-positive donors. Transplant Proc 1991; 23: 1078.
53. Reinke P, Kern F, Fietze E, et al. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients - CD4+ T cells play an essential role in the rejection process. Transplant Proc 1995; 27: 859.
54. Tuso PJ, Cramer DV, Yasunaga C, Cosenza CA, Wu GD, Makowka L. Removal of natural human xenoantibodies to pig vascular endothelium by perfusion of blood through pig kidneys and livers. Transplantation 1993; 55: 1375.